Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Stopped Not enough patient population according to selection criteria to complete the study

Conditions

• Crohn's Disease
• Mucosal Inflammation

Interventions

• DRUG: ADALIMUMAB
• DRUG: Placebo

Sponsor

Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Collaborators

• [object Object]
• [object Object]